|
2 Companies |
|
6 Products |
|
6 Products |
|
10 Mechanisms of Action |
|
0 Trials |
|
53 News |
|
| 12» |
- | Enrollment change: CRAMPS: Assessing Maternal Post-partum Pain With Suppositories (clinicaltrials.gov) - Feb 6, 2018
P4, N=100, Completed, Sponsor: Loyola University
N=217 --> 100
- | ranolazine ER / Generic mfg.
Trial termination: STERILE: Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities (clinicaltrials.gov) - Aug 9, 2017
P=N/A, N=29, Terminated, Sponsor: William Beaumont Hospitals
N=217 --> 100 Completed --> Terminated
- | mexiletine / Generic mfg.
Enrollment change: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - Jul 26, 2017
P4, N=23, Completed, Sponsor: Bjorn Oskarsson, MD
Completed --> Terminated N=30 --> 23
- | NN1213 / Novo Nordisk
Trial completion: Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=38, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
N=30 --> 23 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Diagnostic Evaluation of Patients With Neuromuscular Disease (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=500, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed Recruiting --> Completed
- | Phase classification, Enrollment change, Trial initiation date, Trial termination: Oral Carnitine for Cramps in Pregnancy (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=30, Terminated, Sponsor: University of Southern California
Recruiting --> Completed Phase classification: P2 --> P=N/A | N=150 --> 30 | Initiation date: Aug 2007 --> Jul 2008 | Not yet recruiting --> Terminated; Low interest in study, slow recruitment
- Trial completion: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Sep 20, 2016
P1/2, N=13, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Phase classification: P2 --> P=N/A | N=150 --> 30 | Initiation date: Aug 2007 --> Jul 2008 | Not yet recruiting --> Terminated; Low interest in study, slow recruitment Terminated --> Completed
- Trial termination: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Sep 15, 2016
P1/2, N=13, Terminated, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Terminated --> Completed Enrolling by invitation --> Terminated
- mexiletine / Generic mfg.
Trial completion: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - May 13, 2016
P4, N=30, Completed, Sponsor: Bjorn Oskarsson, MD
Enrolling by invitation --> Terminated Active, not recruiting --> Completed
- Trial completion: Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS (clinicaltrials.gov) - Mar 5, 2016
P3, N=32, Completed, Sponsor: Lawson Health Research Institute
Active, not recruiting --> Completed Recruiting --> Completed
- mexiletine / Generic mfg.
Enrollment closed: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - Jan 20, 2016
P4, N=30, Active, not recruiting, Sponsor: Bjorn Oskarsson, MD
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Trial completion: STOP: Screening To Obviate Preterm Birth (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=589, Completed, Sponsor: University of Pennsylvania
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial primary completion date: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Dec 7, 2015
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
Recruiting --> Completed Trial primary completion date: Oct 2015 --> Oct 2016
- mexiletine / Generic mfg.
Trial primary completion date: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - Dec 4, 2015
P4, N=30, Recruiting, Sponsor: Bjorn Oskarsson, MD
Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Oct 2015 --> Mar 2016
- Trial completion: Investigating the Effectiveness of Intradialytic Massage on Cramping in Dialysis Patients (clinicaltrials.gov) - Oct 5, 2015
P=N/A, N=32, Completed, Sponsor: Catherine Sullivan
Trial primary completion date: Oct 2015 --> Mar 2016 Active, not recruiting --> Completed
- hydroxychloroquine / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Treatment of Muscle Cramps in Patients With Liver Cirrhosis (clinicaltrials.gov) - Aug 12, 2015
P0, N=3, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=10 --> 3 | Trial primary completion date: Dec 2015 --> Apr 2015
- mexiletine / Generic mfg.
Trial primary completion date: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - Jun 11, 2015
P4, N=30, Recruiting, Sponsor: Bjorn Oskarsson, MD
Enrolling by invitation --> Completed | N=10 --> 3 | Trial primary completion date: Dec 2015 --> Apr 2015 Trial primary completion date: Jun 2015 --> Oct 2015
- | propranolol / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Study of Arm and Putter Movement in Golfers With Golfer's Cramp (clinicaltrials.gov) - Apr 8, 2015
P4, N=26, Completed, Sponsor: Mayo Clinic
Trial primary completion date: Jun 2015 --> Oct 2015 Recruiting --> Completed | N=45 --> 26 | Trial primary completion date: Dec 2015 --> Jan 2015
- |||| Trial completion: Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (clinicaltrials.gov) - Mar 17, 2015
P1/2, N=100, Completed, Sponsor: The Canadian College of Naturopathic Medicine
Recruiting --> Completed | N=45 --> 26 | Trial primary completion date: Dec 2015 --> Jan 2015 Active, not recruiting --> Completed
- Enrollment change, Trial termination: Brain Anatomy in Dystonia (clinicaltrials.gov) - Mar 12, 2015
P=N/A, N=189, Terminated, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed N=275 --> 189 | Recruiting --> Terminated
- | Trial completion, Trial primary completion date: The Effects of the Myofascial Trigger Point Injections on Pain and Sleep Disturbance in Patients With Nocturnal Leg Cramps With Trigger Points on Gastrocnemius Muscle (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=13, Completed, Sponsor: Yonsei University
N=275 --> 189 | Recruiting --> Terminated Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Dec 2013
- baclofen / Generic mfg.
New P2 trial: Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study (clinicaltrials.gov) - Nov 24, 2014
P2, N=10, Completed, Sponsor: University of Virginia
- Enrollment status, Enrollment change: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Nov 14, 2014
P1/2, N=1, Enrolling by invitation, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed | Trial primary completion date: May 2013 --> Dec 2013 Recruiting --> Enrolling by invitation | N=16 --> 1
- Trial primary completion date: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Nov 10, 2014
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
Recruiting --> Enrolling by invitation | N=16 --> 1 Trial primary completion date: Feb 2014 --> Oct 2015
- Trial completion, Enrollment change: Quick Start Insertion of Mirena and ParaGard (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=230, Completed, Sponsor: Columbia University
Trial primary completion date: Feb 2014 --> Oct 2015 Active, not recruiting --> Completed | N=400 --> 230
- Trial primary completion date: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Sep 19, 2014
P1/2, N=16, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed | N=400 --> 230 Trial primary completion date: Feb 2015 --> Sep 2016
- ||||| hyoscine butylbromide oral / Generic mfg.
New P2 trial: Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort (clinicaltrials.gov) - Sep 19, 2014
P2, N=527, Completed, Sponsor: Boehringer Ingelheim
- Trial termination: Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (clinicaltrials.gov) - Apr 9, 2014
P4, N=94, Terminated, Sponsor: Uzi Milman
Trial primary completion date: Feb 2015 --> Sep 2016 Recruiting --> Terminated; Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for futility.
- Enrollment change: Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (clinicaltrials.gov) - Apr 9, 2014
P4, N=94, Terminated, Sponsor: Uzi Milman
Recruiting --> Terminated; Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for futility. N=200 --> 94
- Enrollment closed: Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (clinicaltrials.gov) - Apr 9, 2014
P1/2, N=100, Active, not recruiting, Sponsor: The Canadian College of Naturopathic Medicine
N=200 --> 94 Recruiting --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial completion: Amlodipine Plus Botulinum Toxin for Focal Dystonia (clinicaltrials.gov) - Feb 19, 2014
P2, N=16, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Active, not recruiting Recruiting --> Completed
- | propranolol / Generic mfg.
New P4 trial: Study of Arm and Putter Movement in Golfers With Golfer's Cramp (clinicaltrials.gov) - Jan 8, 2014
P4, N=45, Recruiting, Sponsor: Mayo Clinic
- New P1/2 trial: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Dec 17, 2013
P1/2, N=16, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
- Enrollment open: Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp (clinicaltrials.gov) - Dec 12, 2013
P1/2, N=16, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: Investigating the Effectiveness of Intradialytic Massage on Cramping in Dialysis Patients (clinicaltrials.gov) - Oct 23, 2013
P=N/A, N=32, Active, not recruiting, Sponsor: Catherine Sullivan
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- Enrollment closed: Quick Start Insertion of Mirena and ParaGard (clinicaltrials.gov) - Aug 21, 2013
P=N/A, N=400, Active, not recruiting, Sponsor: Columbia University
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Jul 24, 2013
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
Recruiting --> Active, not recruiting N=100 --> 50
- Enrollment closed: Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms (clinicaltrials.gov) - Jul 24, 2013
P2/3, N=50, Active, not recruiting, Sponsor: Catherine Buettner
N=100 --> 50 Recruiting --> Active, not recruiting
- | New P1/2 trial: Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (clinicaltrials.gov) - Jun 25, 2013
P1/2, N=100, Active, not recruiting, Sponsor: The Canadian College of Naturopathic Medicine
- New P1 trial: Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia (clinicaltrials.gov) - Jun 19, 2013
P1, N=18, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
- ranolazine ER / Generic mfg.
Enrollment change: STERILE: Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities (clinicaltrials.gov) - May 20, 2013
P=N/A, N=29, Completed, Sponsor: William Beaumont Hospitals
Recruiting --> Active, not recruiting N=50 --> 29
- ranolazine ER / Generic mfg.
Trial completion: STERILE: Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities (clinicaltrials.gov) - May 20, 2013
P=N/A, N=29, Completed, Sponsor: William Beaumont Hospitals
N=50 --> 29 Active, not recruiting --> Completed
- mexiletine / Generic mfg.
Enrollment open: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - May 8, 2013
P4, N=30, Recruiting, Sponsor: Bjorn Oskarsson, MD
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Amlodipine Plus Botulinum Toxin for Focal Dystonia (clinicaltrials.gov) - Mar 13, 2013
P2, N=16, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting --> Recruiting N=80 --> 16
- mexiletine / Generic mfg.
New P4 trial: Mexiletine for the Treatment of Muscle Cramps in ALS (clinicaltrials.gov) - Mar 12, 2013
P4, N=30, Recruiting, Sponsor: Bjorn Oskarsson, MD
- Trial termination: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection (clinicaltrials.gov) - Feb 2, 2013
P2, N=2, Terminated, Sponsor: Salient Pharmaceuticals Incorporated
N=80 --> 16 Recruiting --> Terminated; Study was stopped for slow enrollment - only 2 patients, no evaluable results
- Enrollment change: Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection (clinicaltrials.gov) - Feb 2, 2013
P2, N=2, Terminated, Sponsor: Salient Pharmaceuticals Incorporated
Recruiting --> Terminated; Study was stopped for slow enrollment - only 2 patients, no evaluable results N=10 --> 2
- Trial completion: CRAMPS: Assessing Maternal Post-partum Pain With Suppositories (clinicaltrials.gov) - Oct 28, 2012
P4, N=217, Completed, Sponsor: Loyola University
N=10 --> 2 Recruiting --> Completed
- New P4 trial: Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (clinicaltrials.gov) - Oct 16, 2012
P4, N=94, Terminated, Sponsor: Uzi Milman
- Trial completion: A Pilot Study of Acupoint Injection for Primary Dysmenorrhea (clinicaltrials.gov) - Apr 17, 2012
P=N/A, N=18, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Active, not recruiting --> Completed